Mindfulness-Based Cognitive Behavioral Therapy as Effective as Pharmacological Intervention
May 10, 2016
The largest ever analysis of mindfulness-based cognitive behavioral therapy was completed under the auspice that “identifying equally efficacious nonpharmacological intervention would be an important development,” as detailed in the study.
The announcement this year that the United States Preventive Services Task Force (USPTF) recommends that all adults over 18 should be screened for depression ignited enthusiasm for individuals around the country hoping to provide more care to the roughly 35 million reluctant care seekers. Another segment of the population worried that with increased assessment the powerful lobbying arms of pharmaceutical companies connected with the pharmacy on every corner would simply promote increased expensive, ambiguous medications. Whereas every other facet of funding for mental health has decreased since the great recession, spending on pharmaceuticals has increased.
The management guru Peter Drucker famously said “if you can measure it you can improve it.” Prevail’s model differs from the unclear use of medication by providing salient details of baseline health, progression, and improvements from utilizing clinical and demographic assessments.
The amazing thing about the mind is that by better understanding our thoughts, behaviors, and emotions, one can start to live a better, happier, and healthier life. Not only this, but the theories taught through mindfulness-cognitive behavioral therapy (MBCT) can be equally as effective alternative to prescribing antidepressants for depression for a fraction of the cost.
Throughout a journey on iPrevail, a user is able to interact with programs built with leading doctors throughout the country – experts in cognitive behavioral therapy. The personalized experience translates proven methods of care online in an accessible and affordable manner. After going through multiple clinical trials including a randomized controlled trial, the program has been shown as effective as face-to-face care.
The study published in JAMA Psychiatry showed that people who received MBCT were a third less likely to experience relapse as opposed to those who did not receive.
“While MBCT is not a panacea, it does clearly offer those with a substantial history of depression a new approach to learning skills to stay well in the long term,” William Kuyken – an Oxford University professor, director of the Oxford Mindfulness Center, and lead author of the study – said in a statement.
Do you want to try practicing mindfulness-based cognitive behavioral therapy? Try it today at iPrevail.com